• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Accelerating discovery: A novel flow cytometric method for detecting fibrin(ogen) amyloid microclots using long COVID as a model


Senior Member


  • Imaging flow cytometry utilizing a novel rapid flow cytometric detection method is a promising method for detecting amyloid fibrin(ogen) microclots in conditions associated with clotting pathology.

  • While this investigation represents a preliminary study, it lays the foundation for further research into the method's utility as a diagnostic tool for individuals with Long COVID.

  • Though challenging, future research can explore potential correlations between microclot detection and specific Long COVID symptoms and comorbidities, enhancing our understanding of the pathophysiology and tools to detect this condition.

  • The method's ability to evaluate amyloid microclot presence, concentration, and size offers valuable insights for clinical applications.

I ask, is there really anything new?